A collaboration between Ontario Power Generation’s (OPG) subsidiary Canadian Nuclear Partners (CNP) and a subsidiary of BWX Technologies, Inc. (BWXT) will make Darlington Nuclear the first large scale commercial nuclear power station worldwide to produce molybdenum-99 (Mo-99). This will help ensure the world’s long term supply of this critical medical isotope, which is used in over 30 million lifesaving diagnostic and medical treatments each year.
Canada
Darlington nuclear to become new source of lifesaving medical isotopes
More Videos
-
Paris 2024: Summer McIntosh wins 2nd gold, sets Olympic record
-
Emancipation Day: Remembering Canada’s history of enslavement
-
Liberal plan for 30-year mortgage amortizations begins
-
Jasper wildfire: Mayor says plan for town visits approved, no clear timeline set yet
-
Jasper wildfire: National park ‘jewel’ largely saved by FireSmart measures, Guilbeault says
-
Witnesses walk out as House committee on violence against women descends into partisan bickering
You are viewing an Accelerated Mobile Webpage.
View Original Article